• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Eleva Reaches Industrial Production Scale & starts Factor H Clinical Development

    BIOSPACE

    Sanofi EVP`s Bioverativ blabbing ends in insider trading cases

    FIERCE PHARMA

    List of centrally authorised products requiring a notification of a change for update of annexes

    EMA

    Advate & Adynovate (Antihemophilic Factor) : Nektar Therapeutics v. Bayer

    PATENT LITIGATION

    Pharma shells out $100B on M&A in 2018 so far: report

    FIERCE PHARMA

    More than $100 Billion Spent on M&A in the First 6 Months of 2018

    BIOSPACE

    Adynovate® (Antihemophilic factor) : Bayer HealthCare LLC v. Nektar Therapeutics

    PATENT LITIGATION

    Shire launches myPKFiT™ for ADVATE® Antihemophilic Factor in the U.S.

    PRESS RELEASE

    Adynovate®(Antihemophilic ): Bayer Healthcare V. Nektar Therapeutics, Baxalta

    PATENT LITIGATION

    CSL Behring receives Health Canada approval for Afstyla to treat hemophilia A

    PHARMABIZ

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.